Prompt BP Control with an Early Combination Therapy: Role of a Fixed-Dose Combination of an ARB and a CCB
Early start of a combination therapy provides prompt blood pressure control and is recommended by international guidelines as well. Renin-angiotensin system inhibitor (RASI), in combination with calcium channel blocker, is one of the most preferred combinations for the early treatment of Hypertension.
Nearly 70% of hypertensive patients do not reach their recommended treatment target blood pressure of <140/90 mmHg with an anti-hypertensive mono-therapy. Adding to this only a small percentage of patients in the high-risk category reach the goal of BP being below 130/80 mmHg. (1)
The above article has been published by Medical Dialogues under the MD Brand Connect Initiative. For more details on Azilsartan, click here